Cubist Systematic Strategies, LLC Lava Therapeutics Nv Transaction History

Cubist Systematic Strategies, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.28 - $4.4 $230 - $444	-101 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.28 - $6.55 $1,284 - $1,965	-300 Reduced 74.81%	101 $0
Q4 2021 Feb 14, 2022	BUY	$4.23 - $7.77 $1,269 - $2,331	300 Added 297.03%	401 $2,000
Q3 2021 Nov 15, 2021	BUY	$5.5 - $11.0 $555 - $1,111	101 New	101 $1,000

3.76M

28K

43.4K

Ticker LVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,797,700
Market Cap $46.4M
Description
LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.